See All AI raises $33M to advance its AI platform that generates 3D surgical images from 2D fluoroscopic X-rays, potentially reducing reliance on pre-op CT and MRI scans.
Key Details
- 1See All AI secured $33 million in funding for its imaging AI platform.
- 2The system converts 2D C-arm fluoroscopic X-rays into 'navigable' 3D volumes.
- 3Aims to reduce the need for pre-operative CT and MRI imaging.
- 4Platform is designed to support minimally invasive surgery workflows.
- 5Technology is not yet FDA-cleared or available clinically; U.S. approval sought this year.
- 6Cadaver studies show capability for high-resolution, cross-plane, 1 mm 3D slices.
Why It Matters
If successful, this technology could streamline surgical planning and reduce costs, radiation, and time in the operating room. It highlights growing industry investment and innovation aimed at augmenting or replacing traditional radiology workflows in perioperative imaging.
Source
Radiology Business
Related News
•AuntMinnie
Study: Computer Vision Models Best LLMs in Chest CT Breast Abnormality Detection
Computer vision models (CVMs) surpass large language models (LLMs) in accurately labeling incidental breast abnormalities on chest CT scans.
•Cardiovascular Business
Radiology Maintains Lead in FDA-Cleared AI Algorithms, Cardiology Follows
Radiology remains the top specialty for FDA-cleared AI, with cardiology as a strong second, particularly in cardiovascular imaging.
•Radiology Business
Private Equity Backs AIRS Medical to Expand MRI AI Globally
TA Associates is investing in AIRS Medical to accelerate its global expansion of AI-powered MRI efficiency solutions.